90/016,178UROLITHIN A AND A COMPOSITION CONTAINING SAME FOR EXTERNAL USE IN INFLAMMATIONS OF VARIOUS ETIOLOGIES12,329,738Open

Status

Non-Final Action Mailed

Filed

Apr 14, 2026

Pre-Order Paper

Filed May 14, 2026

Last Updated

Sep 9, 2026

Art Unit

3991

Requester

Not named (filed by counsel)

Requester Law Firm

Foley Hoag LLP

Requested By

Third Party

Patent Owner(via USPTO assignment records)

MICROBIOTA MED. SP. Z O.O.

Patent Owner Law Firm

Owner hasn't filed yet

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (29 events)

Sep 9, 2026MR.NFRX - Mail Reexam Non-Final Action
Aug 12, 2026RXFWDXDate Forwarded to Examiner
Jun 23, 2026MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Jun 5, 2026MREXORX - Mail Ex Parte Request for Reexamination Granted
Jun 1, 2026IDSCInformation Disclosure Statement considered
May 28, 2026IDSCInformation Disclosure Statement considered
May 28, 2026IDSCInformation Disclosure Statement considered
May 27, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 27, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 27, 2026RXC/SRCertificate of Service
May 14, 2026RXC/SRCertificate of Service
Apr 27, 2026RXLITSRReexam Litigation Search Conducted
Apr 21, 2026MRXNReexamination Formalities Notice Mailed
Apr 21, 2026MRXNReexamination Formalities Notice Mailed
Apr 21, 2026DOCKCase Docketed to Examiner in GAU
Apr 21, 2026COMPApplication Is Now Complete
Apr 20, 2026RXTTLRPTTitle Report
Apr 20, 2026RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Apr 20, 2026RXNREQFDNotice of reexamination request filing date
Apr 20, 2026RXNREQAUNotice of assignment of reexamination request
Apr 15, 2026FTFSFITF set to YES - revise initial setting
Apr 14, 2026RXO_40.CReceipt of Corrected Orig. Ex Parte Request Less Than 40 Pages- Rule 1.20(c )(1)
Apr 14, 2026RXC/SRCertificate of Service
Apr 14, 2026PRXRParalegal Reexam Review Complete
Apr 10, 2026WIDSInformation Disclosure Statement (IDS) Filed
Apr 10, 2026RXOSUBReceipt of Original Ex Parte Reexam Request
Apr 10, 2026RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Apr 10, 2026RXC/SRCertificate of Service
Apr 10, 2026BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Jun 17, 2025
3.5-yr
Dec 17, 2028
7.5-yr
Dec 17, 2032
11.5-yr
Dec 17, 2036
Expiry
Dec 20, 2043

Entity Status

Small Entity

Expires

Dec 20, 2043 (17.7 yr remaining)

Term Adjustment

+932 days (~2.6 yr)

Assignments

20222023FiledSEBASTIAN GRANICAMAREK NARUSZEWICZJAKUB PIWOWARSKIMARIUSZ SACHARCZUKWARSZAWSKI UNIWERSYTET MEDYCZNYWARSZAWSKI UNIWERSYTET MEDYCZNYMICROBIOTA MED. SP. Z O.O.
AssignmentReel/Frame: 056404/0006Recorded: Jun 1, 2021

From

SEBASTIAN GRANICAInventor
May 18, 2021
MAREK NARUSZEWICZInventor
May 20, 2021
JAKUB PIWOWARSKIInventor
May 20, 2021
MARIUSZ SACHARCZUKInventor
May 21, 2021
→

To

WARSZAWSKI UNIWERSYTET MEDYCZNY

AssignmentReel/Frame: 064015/0501Recorded: Jun 21, 2023

From

WARSZAWSKI UNIWERSYTET MEDYCZNY
Jun 13, 2023
→

To

MICROBIOTA MED. SP. Z O.O.